Close
Close
AOD-9604

AOD-9604 3-Month Membership Program

$2,700.00

4.9 Avg. Rating

1000+ Reviews

  • Follow-up Exam
  • Lab Review
  • Dose Adjustments
  • Certificate of Authenticity
  • 503A Pharmacies
  • 99% Pure
  • US-based Peptides
AOD-9604 is a small peptide that was originally developed by scientists studying a specific part of human growth hormone. Rather than using the entire growth hormone molecule, researchers isolated a small fragment of it, specifically the piece believed to be involved in fat metabolism, without carrying the growth-promoting effects associated with full growth hormone.
AOD-9604 does not occur naturally in the body in this exact form. It was designed and synthesized in a laboratory setting as researchers explored whether isolating this fragment could offer a more targeted approach to supporting fat metabolism, without some of the broader effects seen with full growth hormone therapy.
Patients often ask about AOD-9604 after learning about its history in early clinical research related to weight management. It has been studied as part of a broader interest in the connection between growth hormone pathways and how the body regulates and breaks down fat.
It’s important to understand upfront that AOD-9604 has a mixed research history. While early laboratory and animal research generated interest, human clinical trials produced inconsistent results, and it has not been approved by the FDA as a treatment for weight loss or any other condition. This page is intended to give you a clear, honest picture of what AOD-9604 is and what the current evidence actually shows, rather than an inflated picture of its potential.
To understand AOD-9604, it helps to picture growth hormone as a long chain, made up of many connected sections, each responsible for different jobs in the body. One section of that chain appears to be linked to how the body breaks down and uses stored fat for energy. Scientists isolated just that section and studied it on its own. The idea behind AOD-9604 was to take advantage of the fat-metabolism-related section of growth hormone while leaving out the sections responsible for other effects, such as tissue growth. Think of it like removing one tool from a large, multi-tool kit, in hopes that the single tool could be used on its own without needing the rest of the kit. In laboratory and animal studies, researchers observed some effects on fat breakdown when this fragment was introduced. However, when the compound moved into human clinical trials, the results were far less consistent than researchers had hoped, and the mechanism in humans is not as clearly established as it is in early laboratory models.
Because AOD-9604’s research history includes both promising early findings and later inconsistent human trial results, its potential benefits should be discussed with real caution:
  • Has been studied for its possible role in fat metabolism, based on its origin as a growth-hormone-related fragment
  • Was investigated in early research for a possible connection to weight management support, though later human studies did not consistently confirm this effect
  • Continues to be of interest in laboratory and animal research exploring how growth hormone pathways relate to fat breakdown
  • Is sometimes discussed in the context of body composition research, although strong, consistent human evidence supporting this use is currently lacking
At this time, there is not strong, consistent human clinical evidence to support AOD-9604 as an effective standalone weight management therapy. Any discussion of potential benefits should be understood in the context of this limited and mixed research history.
People who ask about AOD-9604 are typically individuals who are:
  • Interested in the history and science of growth-hormone-related peptide research
  • Exploring options related to weight management or body composition alongside a licensed provider
  • Curious about early-stage or investigational compounds discussed in longevity and wellness spaces
  • Looking for an honest, evidence-based conversation about a peptide they’ve read about online
Because of the limitations in current human research, AOD-9604 is not appropriate for everyone, and it should never be viewed as a guaranteed or primary solution for weight loss. Any decision to explore this peptide should happen only after a full medical evaluation and an honest conversation about what the evidence does and does not show.
AOD-9604’s research history is a helpful example of how early scientific interest doesn’t always translate into confirmed human benefits. In early laboratory and animal studies, researchers observed effects related to fat breakdown when the fragment was introduced, which generated meaningful interest in its potential as a weight management compound. However, when AOD-9604 was studied in human clinical trials during the 2000s, including trials exploring its use for obesity, results did not consistently show significant weight loss benefits compared to placebo. This gap between early laboratory promise and human clinical results is an important part of AOD-9604’s story, and it’s a big reason why it has not been approved by regulatory agencies, including the FDA, for use as a weight management treatment. Since those earlier trials, AOD-9604 has continued to appear in scientific literature, primarily in laboratory and animal-based research rather than large, well-controlled human studies. Some smaller or less rigorous studies and anecdotal reports exist, but they do not carry the same weight as controlled clinical trials. Researchers who study growth hormone fragments continue to explore related compounds, but AOD-9604 specifically does not currently have strong, consistent human evidence behind it. Given this history, it’s especially important for patients to understand that research in this area is limited, mixed, and still evolving, and that individual responses, where anecdotally reported, can vary widely and are not well supported by controlled data.
Because AOD-9604 has been studied in earlier human trials, some safety data does exist, though it is not as extensive as data available for many other peptides used in modern telehealth practice. Possible side effects reported in prior research and general use have included injection site or administration-related reactions, mild digestive symptoms, and headaches in some individuals. Because comprehensive, large-scale safety data in diverse populations is limited, providers approach AOD-9604 conservatively. AOD-9604 may not be an appropriate option for people who are pregnant or breastfeeding, individuals with certain hormone-sensitive conditions, or those with significant unmanaged health conditions. A full medical history is necessary before any decision is made about whether this peptide is appropriate for you. Medical supervision is especially important with a compound like AOD-9604, given its mixed research history and more limited safety data compared to other therapies. A licensed provider can help you understand realistic expectations, monitor for any side effects, and determine whether this peptide fits appropriately into your overall health plan. Following your prescribed plan and attending scheduled follow-ups allows your provider to make adjustments as needed and supports a safer overall experience.

What does AOD-9604 do?

AOD-9604 is a peptide fragment originally derived from growth hormone that has been studied for a possible role in fat metabolism. However, human research results have been mixed, and it is not an approved weight loss treatment.

How long before I may notice changes?

Because human research on AOD-9604 has not consistently shown clear, measurable effects, providers are careful not to set specific timelines for expected changes. Your provider will give you an honest, individualized perspective.

Is AOD-9604 an injection?

AOD-9604 has historically been studied and used in injectable form, but it is also available in oral capsule form, which some patients find more convenient.

Can AOD-9604 be combined with other peptides?

This depends on your individual health history and goals. Your provider will review your full treatment plan before making any recommendations about combining therapies.

Can AOD-9604 be combined with GLP-1 medications?

Any combination of therapies should only be considered after a full provider review of your medical history and current medications, since safety data on specific combinations is limited.

Will I need lab work?

Yes. Your provider may recommend baseline and periodic lab testing to help monitor your overall health while using this therapy.

Who should avoid AOD-9604?

People who are pregnant or breastfeeding, those with certain hormone-sensitive conditions, or individuals with significant unmanaged health conditions may not be appropriate candidates. A medical evaluation will help determine this.

How long do patients typically remain on therapy?

Treatment length varies and is determined by your provider based on your individual goals, health status, and response, if any, over time.

Is a consultation required?

Yes. A telehealth consultation with a licensed provider is required before starting AOD-9604 to determine whether it is an appropriate and safe option for you.

Is AOD-9604 FDA-approved for weight loss?

No. AOD-9604 is not an FDA-approved treatment for weight loss or any other condition. It has a history of investigational research, and providers discuss it with patients in that honest context.
Every peptide and prescription wellness therapy program at SevenHealth is designed to be thorough, transparent, and medically supervised from start to finish. When you begin treatment, your program includes:
  • An initial telehealth medical history and comprehensive evaluation with a licensed medical provider
  • Review of previous laboratory results when available, or recommendations for laboratory testing when medically appropriate
  • Personalized treatment recommendations based on your individual medical history and health goals
  • Three months of prescribed therapy when medically appropriate
  • A customized dosing and titration schedule specific to your prescribed treatment
  • A comprehensive follow-up appointment approximately three months after starting treatment
  • Review of your progress, discussion of results, treatment adjustments if medically appropriate, and continued provider guidance
  • Ongoing provider oversight throughout your entire treatment program
  • No additional fees for appointments included within the treatment program
  • No additional fees for laboratory review as part of your treatment
Our goal at SevenHealth is to make your experience with prescription wellness therapy simple, transparent, and medically sound from your very first consultation through every follow-up along the way.
SevenHealth focuses on individualized, provider-guided care rather than a one-size-fits-all approach. Every treatment plan is built around your specific health history, lab results, and personal goals. Patients choose SevenHealth because of:
  • Personalized treatment plans built around individual health needs
  • Licensed medical providers overseeing every step of care
  • Provider-guided dosing rather than generic, self-directed protocols
  • Medications sourced through FDA-registered 503A U.S. compounding pharmacies that follow applicable quality standards
  • Ongoing medical supervision throughout the entire treatment period
  • A structured three-month follow-up built into every program
  • Transparent pricing, with no surprise appointment or lab review fees within the treatment program
This approach is designed to support informed, safe decision-making rather than promote any single therapy as a one-size-fits-all solution.
  • AOD-9604 is a peptide fragment originally derived from human growth hormone
  • It was studied in early research for a possible role in fat metabolism
  • Human clinical trial results have been inconsistent, and it is not FDA-approved for weight loss
  • AOD-9604 is available in oral capsule form
  • Current human evidence is limited compared to other peptides, and safety data is less extensive
  • It is not appropriate as a guaranteed or standalone weight loss solution
  • A full medical evaluation and honest discussion of the evidence are essential before considering this therapy
  • SevenHealth provides ongoing provider oversight, lab review, and structured follow-up for anyone considering this therapy

Educational Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy should only be used under the supervision of a licensed healthcare provider after an appropriate medical evaluation. Individual results may vary.

$100 OFF GLP-1 Injectable Plans for New Members ! CODE: